683812-95-5

Basic information

• Product Name: Benzoic acid, 4-[2-[5-chloro-2-[2-[[[(3,5-dichlorophenyl)methyl]sulfonyl]amino]ethyl]-1-( diphenylmethyl)-1H-indol-3-yl]ethoxy]-, methyl ester
• CAS NO: 683812-95-5
• Molecular Formula: C40H35Cl3N2O5S
• Molecular Weight: 762.153
• Mol File: 683812-95-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-[2-[5-chloro-2-[2-[[[(3,5-dichlorophenyl)methyl]sulfonyl]amino]ethyl]-1-( diphenylmethyl)-1H-indol-3-yl]ethoxy]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[2-[5-chloro-2-[2-[[[(3,5-dichlorophenyl)methyl]sulfonyl]amino]ethyl]-1-( diphenylmethyl)-1H-indol-3-yl]ethoxy]-, methyl ester(683812-95-5)
• EPA Substance Registry System: Benzoic acid, 4-[2-[5-chloro-2-[2-[[[(3,5-dichlorophenyl)methyl]sulfonyl]amino]ethyl]-1-( diphenylmethyl)-1H-indol-3-yl]ethoxy]-, methyl ester(683812-95-5)

Safety Data

• Hazardous Substances Data: 683812-95-5(Hazardous Substances Data)

Upstream product

• 479422-26-9 methyl 4-{2-[5-chloro-1-(diphenylmethyl)-2-formyl-1H-indol-3-yl]ethoxy}benzoate 
• 683813-75-4 C₃₂H₂₆Br₂ClNO₃ 
• 934284-96-5 methyl 4-(2-{5-chloro-1-(diphenylmethyl)-2-[(E)-2-nitrovinyl]-1H-indol-3-yl}ethoxy)benzoate 
• 540522-69-8 methyl 4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate amine 
• 163295-70-3 (3,5-dichlorophenyl)methanesulfonyl chloride 
• 479422-24-7 methyl 4-[2-[5-chloro-(1-diphenylmethyl)-2-methyl-1H-indol-3-yl]ethoxy]benzoate 

Relevant articles and documents

Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis

This invention provides methods for the use of substituted indole compounds of the general formula: and pharmaceutically acceptable salt forms thereof. The invention provides methods for the use of the compounds in the treating or preventing thrombosis in a mammal, or preventing progression of symptoms of thrombosis.

Process for making an aldehyde

A process for making an aromatic aldehyde in which a sulfoxide is reacted with a dihalogenated aromatic compound in the absence of an effective amount of an activating reagent. The aldehyde may then be used to make other compounds, such as a compound that acts as a cPLA inhibitor.